| Company Name: |
Borenpharm Co., Ltd
|
| Tel: |
027-65563561 |
| Email: |
sales@borenpharm.com |
| Products Intro: |
Product Name:CH2COOH-PEG6-CH2COOH
CAS:83824-29-7
Purity:95% HPLC Package:1g; 5g Remarks:2g
|
|
| | HOOCCH2O-PEG6-CH2COOH Basic information |
| Product Name: | HOOCCH2O-PEG6-CH2COOH | | Synonyms: | HOOCCH2O-PEG6-CH2COOH;HOOCCH2O-PEG6-CH2COOH/3,6,9,12,15,18,21-Heptaoxatricosanedioic acid;3,6,9,12,15,18,21-Heptaoxatricosanedioic acid;COOH-CH2-PEG6-OCH2COOH;3,6,9,12,15,18,21-Heptaoxatricosane-1,23-dioic Acid | | CAS: | 83824-29-7 | | MF: | C16H30O11 | | MW: | 398.4 | | EINECS: | | | Product Categories: | | | Mol File: | 83824-29-7.mol |  |
| | HOOCCH2O-PEG6-CH2COOH Chemical Properties |
| Boiling point | 554.0±45.0 °C(Predicted) | | density | 1.220±0.06 g/cm3(Predicted) | | storage temp. | Storage temp. 2-8°C | | form | Viscous Liquid | | pka | 3.09±0.10(Predicted) | | color | Light yellow to yellow |
| | HOOCCH2O-PEG6-CH2COOH Usage And Synthesis |
| Uses | CH2COOH-PEG6-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | HOOCCH2O-PEG6-CH2COOH Preparation Products And Raw materials |
|